SPECTRUM PHARMACEUTICALS INC Patent Applications Rejected
4 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-03-03: Application 18177787; Invention METHODS FOR PROMOTING ANTI-TUMOR IMMUNE RESPONSE IN A SUBJECT IN NEED THEREOF USING ENCAPSULATED INTERLEUKIN 12; Applicant Spectrum Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2022-11-21: Application 18057239; Invention INHIBITORS OF MUTANT FAMILY TYROSINE-KINASES; Applicant Spectrum Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2021-03-22: Application 17278397; Invention NOVEL QUINAZOLINE EGFR INHIBITORS; Applicant Spectrum Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2021-03-11: Application 17275290; Invention KITS AND METHODS FOR TREATING CANCERS; Applicant Spectrum Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2023-03-03 | 18177787 | METHODS FOR PROMOTING ANTI-TUMOR IMMUNE RESPONSE IN A SUBJECT IN NEED THEREOF USING ENCAPSULATED INTERLEUKIN 12 | Spectrum Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20230277628A1 | Sribalaji Lakshmikanthan Prasad Kolli Francois Lebel John A. Barrett | United States United States United States United States | BELYAVSKYI, MICHAIL A |
| 2022-11-21 | 18057239 | INHIBITORS OF MUTANT FAMILY TYROSINE-KINASES | Spectrum Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20230106731A1 | Prasad V. Chaturvedula Prasad Kolli | United States United States | RAO, DEEPAK R |
| 2021-03-22 | 17278397 | NOVEL QUINAZOLINE EGFR INHIBITORS | Spectrum Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20210353627A1 | Prasad V. Chaturvedula | United States | NOTTINGHAM, KYLE GREGORY |
| 2021-03-11 | 17275290 | KITS AND METHODS FOR TREATING CANCERS | Spectrum Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220040180A1 | Guru Reddy | United States | ANDERSON, JAMES D |